PRESS RELEASE: FDA Authorizes Injection of DNG64-CAR-V Gene Therapy into CSF for 2nd Patient with Leptomeningeal Disease

An innovative way of administering DNG64-CAR-V for treatment of brain tumors, leukemia, lymphoma, and cancers that have spread to the brain and spinal cord